Merit Medical Systems, Inc. (MMSI) SEC Filings & Earnings Calls

Transition risk during COO departure, though mitigated by senior advisor role

“Mr. Peterson will move into the role of Senior Advisor, where he will help ensure a smooth transition through March 5, 2027.” · word for word

Free cash flow declined 14% YTD despite higher earnings, possibly due to working capital.

“Free cash flow* generation of $76.6 million year-to-date, down 14%” · word for word

Tariff Uncertainty

“Significant uncertainty remains regarding how and when any remaining amounts may be recovered, including the potential recovery for certain tariffs paid relating to raw materials and products for which the Company is not the importer of record.” · word for word

Supply Chain Disruption

“Cash used for inventories was $43.6 million and $11.7 million for the six-month periods ended June 30, 2026 and 2025, respectively. The increase in inventories during 2026 was principally associated with our strategy to proactively invest in our inventory balances to encourage high customer service levels, as well as to expand inventory balances for newly-ac” · word for word

Tariff recovery uncertainty

“Significant uncertainty remains regarding how and when any amounts may be recovered. We are evaluating the ruling and potential actions available to us.” · word for word

Inventory investment risk

“Cash used for inventories was $22.7 million and $10.6 million for the three-month periods ended March 31, 2026 and 2025, respectively. The increase in inventories during 2026 was principally associated with our strategy to proactively invest in our inventory balances to encourage high customer service levels, as well as to build bridge inventory for producti” · word for word

Integration risk and dilution to GAAP earnings in 2026 and 2027.

“dilutive to Merit’s full-year 2026 GAAP net income and GAAP earnings per share ... dilutive to Merit’s GAAP net income and GAAP earnings per share in 2027” · word for word

CEO Transition Risk

“CEO transition plan ... Martha G. Aronson became President and CEO ... Fred P. Lampropoulos ... retired”

Integration Risk from Acquisitions

“acquisitions of (i) the C2 CryoBalloon® device and related technology from Pentax and (ii) the hemostatic devices ... from Biolife” · word for word

China VBP Policy Impact

“China’s VBP policy has negatively impacted our product pricing and revenue in China since 2022.” · word for word

Tariff-Induced Cost Increases

“Many of the announced tariffs apply to countries from which we import our raw materials, component parts and finished products, including Mexico, Ireland and China, and have increased our manufacturing costs.” · word for word

Input Cost Inflation Persistence

“During 2025, we experienced significantly elevated commodity and supply chain costs, including the costs of labor, raw materials, energy, packaging materials and other inputs necessary for the production and distribution of our products.” · word for word

Leadership Transition Risk

“Effective October 3, 2025, Fred Lampropoulos resigned as Chief Executive Officer and President of Merit and Merit’s Board of Directors appointed Martha G. Aronson as a Director and as Merit’s new Chief Executive Officer and President.” · word for word

Acquisition Integration Risk

“The benefits we expect from the Recent Acquisitions are based on projections and assumptions about the performance of the acquired assets under our ownership, which may not materialize as expected.” · word for word

OEM segment revenue declined 15% in Q4, possibly due to spine reclassification or demand weakness.

“OEM revenue $48.1M down 15% in Q4; FY2025 +2%”

Foreign exchange headwind impacted reported revenue by ~$4.4M in Q4 and ~$5.2M for FY2025.

“Impact of foreign exchange: Q4 ($4,395), FY ($5,173)”

Leadership transition risk with founder departure

“Founder and former CEO resigned from board, though consulting agreement in place.”

Reimbursement uncertainty may slow adoption; company pivots to direct commercialization without TPT payment.

“Our efforts to secure incremental payment in the outpatient and ASC settings have impacted the pace of U.S. commercialization” · word for word

Integration risk and uncertainty about achieving projected financial results from the acquisition.

“inherent risks and uncertainties associated with the C2 CryoBalloon Acquisition, Merit’s integration of the C2 CryoBalloon assets and operations and its ability to achieve projected financial results” · word for word

Potential impact from trade policies and related actions; foreign exchange headwinds.

“absent the potential impact of trade policies and related actions implemented by” · word for word

Tariff impact on production costs

“The United States recently announced changes to its trade policies, including increasing tariffs on imports, in some cases significantly... which could negatively affect our business, results of operations and financial condition.” · word for word

SG&A expense growth outpacing sales growth

“SG&A expenses increased $20.2 million, or 20.2%, for the three-month period ended September 30, 2025 compared to the corresponding period of 2024.” · word for word